Healthcare Quarterly

Healthcare Quarterly 8(3) May 2005 : 65-68.doi:10.12927/hcq.2005.20375

Commentary: Sticking to the Knitting: CIHR, Innovation and Canadian Biotech

Jeff Edelson


The novel proposal outlined by Glenn Brimacombe suggests that the federal government directly participate in funding incremental venture capital investment in Canadian biotechnology, with the goal of facilitating commercialization of Canadian biotechnology and health sciences intellectual property. In this way, they suggest, the economic development benefits of the Canadian current investment in health sciences will be increased.



Be the first to comment on this!

Note: Please enter a display name. Your email address will not be publically displayed